Professional Documents
Culture Documents
9]||ClickheretodownloadfreeAndroidapplic
Invited Article
ABSTRACT
Th
a is
si P
te D
ho F
st is
ed av
by aila
m Me ble
ed dk fo
kn no r f
ow w ree
.c Pu d
om b ow
). lica nlo
tio a
ns d f
(w rom
w
w.
An increase in drug safety concerns in recent years with some high profile drug withdrawals
have led to raising the bar by various stakeholders more importantly by the regulatory
authorities. The number of Adverse Drug Reactions (ADRs) reported have also resulted in
an increase in the volume of data handled and to understand pharmacovigilance a high
level of expertise is required to rapidly detect drug risks as well as to defend the product
against an inappropriate removal.
Correspondence to:
Pipasha Biswas,
MD MPM DM
Principal Consultant & Director
Pharmacovigilance &
Pharmacoepidemiology
Symogen Ltd, UK.
E-mail: b_pipasha@yahoo.co.uk
Proactive pharmacovigilance throughout the product life cycle is the way forward and
the future direction for drug safety. It is a challenge to codify and standardize the act of
signal detection and risk management in the context of clinical trials and post-marketing
pharmacovigilance. While major advancements of the discipline of oharmacovigilance
have taken place in the West, not much has been achieved in India. However, with
more clinical trials and clinical research activity being conducted in India, there is an
immense need to understand and implement pharmacovigilance. For this to happen in
India, the mind set of people working in regulatory agency (DCGI Office) and the Indian
Pharmaceutical companies need to change. This article describes and discusses the various
strategies and proposals to build, maintain and implement a robust pharmacovigilance
system for various stakeholders and eventually make it happen in India!
KEY WORDS: Proactive pharmacovigilance, signal detection, risk management, strategies
and Proposals, robust pharmacovigilance system, pharmacovigilance training and
knowledge
Indian J Pharmacol
have taken place in the Western countries, not much has been
achieved in India. However, with more and more clinical trials
and other clinical research activities being conducted in India,
there is an immense need to understand the importance of
pharmacovigilance and how it impacts the life cycle of the
product. This will enable integration of good pharmacovigilance
practice in the processes and procedures to help ensure
regulatory compliance and enhance clinical trial safety and
postmarketing surveillance.
Brief history of Pharmacovigilance in India
Even though pharmacovigilance is still in its infancy, it is
not new to India. It was not until 1986 that a formal adverse
drug reaction (ADR) monitoring system consisting of 12 regional
centers, each covering a population of 50 million, was proposed
for India.[2] However, nothing much happened until a decade
later when in 1997, India joined the World Health Organization
(WHO) Adverse Drug Reaction Monitoring Programme based
in Uppsala, Sweden. Three centers for ADR monitoring were
identified, mainly based in teaching hospitals: a National
Pharmacovigilance Centre located in the Department of
[Downloadedfreefromhttp://www.ijp-online.comonSaturday,February04,2012,IP:59.98.192.9]||ClickheretodownloadfreeAndroidapplic
Biswas, et al.: Setting standards for proactive pharmacovigilance in India: The Way Forward
Th
si is P
te D
ho F
st is
ed av
by aila
m Me ble
ed dk fo
kn no r f
ow w ree
.c Pu d
om b ow
). lica nlo
tio a
ns d f
(w rom
w
w.
Indian J Pharmacol
125
[Downloadedfreefromhttp://www.ijp-online.comonSaturday,February04,2012,IP:59.98.192.9]||ClickheretodownloadfreeAndroidapplic
Biswas,
et al.: Setting standards for proactive pharmacovigilance in India: The Way Forward
Figure 1: Proactive pharmacovigilance: the way forward in India
Th
a is
si P
te D
ho F
st is
ed av
by aila
m Me ble
ed dk fo
kn no r f
ow w ree
.c Pu d
om b ow
). lica nlo
tio a
ns d f
(w rom
w
w.
126
Indian J Pharmacol
[Downloadedfreefromhttp://www.ijp-online.comonSaturday,February04,2012,IP:59.98.192.9]||ClickheretodownloadfreeAndroidapplic
Biswas, et al.: Setting standards for proactive pharmacovigilance in India: The Way Forward
Th
si is P
te D
ho F
st is
ed av
by aila
m Me ble
ed dk fo
kn no r f
ow w ree
.c Pu d
om b ow
). lica nlo
tio a
ns d f
(w rom
w
w.
Indian J Pharmacol
127
[Downloadedfreefromhttp://www.ijp-online.comonSaturday,February04,2012,IP:59.98.192.9]||ClickheretodownloadfreeAndroidapplic
Biswas,
et al.: Setting standards for proactive pharmacovigilance in India: The Way Forward
Th
a is
si P
te D
ho F
st is
ed av
by aila
m Me ble
ed dk fo
kn no r f
ow w ree
.c Pu d
om b ow
). lica nlo
tio a
ns d f
(w rom
w
w.
128
Indian J Pharmacol
References
1.
2.
3.
4.
5.
6.
7.
8.